Does GnRH agonist enhance the final adult height in girls with precocious puberty?
暂无分享,去创建一个
C. Bongsebandhu-phubhakdi | S. Wacharasindhu | S. Aroonparkmongkol | T. Sahakitrungrueng | V. Supornsilchai
[1] S. Wacharasindhu,et al. Pubertal growth in normal Thai children: a longitudinal study , 2010 .
[2] S. Cesario,et al. Precocious puberty: a comprehensive review of literature. , 2007, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.
[3] M. Phillip,et al. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. , 2002, The Journal of clinical endocrinology and metabolism.
[4] K. Klein,et al. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. , 2001, The Journal of clinical endocrinology and metabolism.
[5] A. Rogol. Early menarche and adult height: reprise of the hare and the tortoise? , 2001, The Journal of pediatrics.
[6] E. Obarzanek,et al. Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study. , 2001, The Journal of pediatrics.
[7] J. Coste,et al. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. , 1999, The Journal of clinical endocrinology and metabolism.
[8] A. Balsamo,et al. Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5–8.5 years , 1999, Archives of disease in childhood.
[9] A. Pasquino,et al. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. , 1999, European journal of endocrinology.
[10] J. Carel,et al. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty. , 1999, The Journal of clinical endocrinology and metabolism.
[11] Z. Laron,et al. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. , 1997, Hormone research.
[12] P. Saenger,et al. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. , 1995, The Journal of pediatrics.
[13] S. Bernasconi,et al. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone‐releasing hormone agonist treatments , 1994, Acta paediatrica.
[14] G. Kletter,et al. Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. , 1994, The Journal of clinical endocrinology and metabolism.
[15] P. Hindmarsh,et al. Sexual precocity: sex incidence and aetiology. , 1994, Archives of Disease in Childhood.
[16] J M Tanner,et al. Standards for Children's Height at Ages 2-9 Years Allowing for Height of Parents , 1970, Archives of disease in childhood.
[17] N. Bayley,et al. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. , 1952, The Journal of pediatrics.
[18] H. Vignes. [Precocious puberty]. , 1950, Journal des praticiens; revue generale de clinique et de therapeutique.